Millennium Management
OGEN icon

Millennium Management’s Oragenics OGEN Stock Holding History

Millennium Management’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-60
Closed -$24K – 6902
2022
Q3 		$24K Sell
60
-12
-17% -$7.01K ﹤0.01% 6413
2022
Q2 		$45K Buy
72
+62
+620% +$35.8K ﹤0.01% 6234
2022
Q1 		$6K Buy
10
+4
+67% +$2.93K ﹤0.01% 6767
2021
Q4 		$5K Sell
6
-4
-40% -$4.05K ﹤0.01% 6682
2021
Q3 		$11K Sell
10
-5
-33% -$6.03K ﹤0.01% 6688
2021
Q2 		$19K Buy
+15
New +$19.7K ﹤0.01% 6431

Other funds holding OGEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SBF
Sara-Bay Financial Sarasota, Florida $375M AUM 56.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management's OGEN Position: Q4 2022 in Review

Millennium Management sold out of Oragenics (OGEN) in Q4 2022, closing a stake of 60 shares — an estimated $24K sold.

Millennium Management first reported a position in OGEN in Q2 2021 and held it in 6 quarters. The position peaked at $45K in Q2 2022. 24 funds tracked by Wall St. Rank hold OGEN as of Q4 2022.

  • Millennium Management reported no remaining Oragenics position as of Q4 2022 after selling out during the quarter.
  • Millennium Management sold 60 Oragenics shares in Q4 2022, an estimated $24K.
  • Millennium Management first reported a position in Oragenics in Q2 2021 and held it in 6 quarters.
  • Millennium Management's Oragenics position peaked at $45K in Q2 2022.
  • 24 funds tracked by Wall St. Rank held Oragenics as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.